SUN-311 A Rare Case of Hypercalcemia in Decompensated Liver Cirrhosis

Abstract C. Arima: None. M. Allam: None. S. Mahesh: None. C.E. Guillen Lopez: None. We present a 65-year-old male with past medical history of suspected NASH-induced decompensated liver cirrhosis who was transferred from an outside hospital for further evaluation for a liver transplant. Hospital admission was complicated by spontaneous bacterial peritonitis treated with antibiotics, portal vein thromboses, ascites status post multiple paracentesis, newfound coronary artery disease making patient no longer a candidate for transplant. On physical examination, the patient had severe abdominal distension, jaundiced skin with icterus, but was not encephalopathic. Labs revealed elevated liver enzymes that continued to worsen, and a bilirubin level that peaked at 9.9. The patient also subsequently developed new onset hypercalcemia, with calcium levels peaking at 11.1. Extensive workup for hypercalcemia was ordered. Intact PTH, PTH related protein, and AFP were within normal limits, excluding parathyroid or malignancy related causes of hypercalcemia. Vitamin D levels were low, ruling out Vitamin D toxicity. TSH levels were normal, and a thyroid ultrasound was unrevealing, ruling out thyroid related causes as well. Patient developed suspected contrast- induced nephropathy throughout the admission, but calcium levels were still elevated even after patient’s kidney function improved. A 24- hour urine calcium was unable to be performed due to the patient being on diuretics. There was no family history of familial hypocalciuric hypercalcemia and prior to hospitalization, the patient did not have any restricted mobility or periods of prolonged immobilization. After excluding the usual causes of hypercalcemia, it was presumed that the hypercalcemia was secondary to patient’s decompensated liver disease. The pathogenesis of cirrhosis-induced hypercalcemia is poorly studied and not well understood. It is hypothesized that acute decompensation of cirrhosis can lead to an increased inflammatory state, resulting in inflammatory mediators being released causing bone resorption and consequent hypercalcemia. Therefore, hypercalcemia in cirrhosis should be a diagnosis of exclusion and rigorous workup of other causes of hypercalcemia should be thoroughly explored first. Sunday, June 2, 2024

Authors

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2024-10-01
DOI
https://doi.org/10.1210/jendso/bvae163.2322
Primary Topic
Bone health and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SUN-311 A Rare Case of Hypercalcemia in Decompensated Liver Cirrhosis

Chloe Arima, Claudia Estefania Guillen Lopez, Mounika Lakshmi Allam, Sarah Fatima et al.
Journal of the Endocrine Society
Bone health and treatments
article

SUN-311 A Rare Case of Hypercalcemia in Decompensated Liver Cirrhosis

Chloe Arima, Claudia Estefania Guillen Lopez, Mounika Lakshmi Allam, Sarah Fatima, Shweta Mahesh
article en

Abstract

Abstract C. Arima: None. M. Allam: None. S. Mahesh: None. C.E. Guillen Lopez: None. We present a 65-year-old male with past medical history of suspected NASH-induced decompensated liver cirrhosis who was transferred from an outside hospital for further evaluation for a liver transplant. Hospital admission was complicated by spontaneous bacterial peritonitis treated with antibiotics, portal vein thromboses, ascites status post multiple paracentesis, newfound coronary artery disease making patient no longer a candidate for transplant. On physical examination, the patient had severe abdominal distension, jaundiced skin with icterus, but was not encephalopathic. Labs revealed elevated liver enzymes that continued to worsen, and a bilirubin level that peaked at 9.9. The patient also subsequently developed new onset hypercalcemia, with calcium levels peaking at 11.1. Extensive workup for hypercalcemia was ordered. Intact PTH, PTH related protein, and AFP were within normal limits, excluding parathyroid or malignancy related causes of hypercalcemia. Vitamin D levels were low, ruling out Vitamin D toxicity. TSH levels were normal, and a thyroid ultrasound was unrevealing, ruling out thyroid related causes as well. Patient developed suspected contrast- induced nephropathy throughout the admission, but calcium levels were still elevated even after patient’s kidney function improved. A 24- hour urine calcium was unable to be performed due to the patient being on diuretics. There was no family history of familial hypocalciuric hypercalcemia and prior to hospitalization, the patient did not have any restricted mobility or periods of prolonged immobilization. After excluding the usual causes of hypercalcemia, it was presumed that the hypercalcemia was secondary to patient’s decompensated liver disease. The pathogenesis of cirrhosis-induced hypercalcemia is poorly studied and not well understood. It is hypothesized that acute decompensation of cirrhosis can lead to an increased inflammatory state, resulting in inflammatory mediators being released causing bone resorption and consequent hypercalcemia. Therefore, hypercalcemia in cirrhosis should be a diagnosis of exclusion and rigorous workup of other causes of hypercalcemia should be thoroughly explored first. Sunday, June 2, 2024

Journal of the Endocrine SocietyVol. 8(Supplement_1)
Loyola University Medical Center (US), Loyola University Chicago (US), Loyola Medicine (US)
Openalex Percentile: Top 57%
Bone health and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.